Page 151 - 《南京医科大学学报》自然科学版2026年第2期

第46卷第2期 乔烨甜，李小杉，吴 波. 肺移植术后闭塞性细支气管炎的研究进展［J］.
2026年2月 南京医科大学学报（自然科学版），2026，46（2）：299-308 ·307 ·

［29］ DRISKEL M，HORSLEY A，FRETWELL L，et al. Lung Med，2024，12（1）：34-44
clearance index in detection of post⁃transplant bronchio⁃ ［40］ NEUROHR C，KNEIDINGER N，GHIANI A，et al. A
litis obliterans syndrome［J］. ERJ Open Res，2019，5（4）： randomized controlled trial of liposomal cyclosporine A
00164-02019 for inhalation in the prevention of bronchiolitis obliterans
［30］LEVY L，MOSHKELGOSHA S，HUSZTI E，et al. Pulmo⁃ syndrome following lung transplantation［J］. Am J Trans⁃
nary epithelial markers in phenotypes of chronic lung plant，2022，22（1）：222-229
allograft dysfunction［J］. J Heart Lung Transplant，2023， ［41］SUILIK H A，AL⁃SHAMMARI A S，SOLIMAN Y，et al.
42（8）：1152-1160 Efficacy of tacrolimus versus cyclosporine after lung
［31］ SCHULTZ H H L，DAVIDSEN J R. Thoracic ultrasound transplantation：an updated systematic review，meta ⁃
in lung transplantation ⁃ insights in the field［J］. Life analysis，and trial sequential analysis of randomized
（Basel），2023，13（3）：695 controlled trials［J］. Eur J Clin Pharmacol，2024，80（12）：
［32］WALKUP L L，MYERS K，EL⁃BIETAR J，et al. Xenon⁃ 1923-1935
129 MRI detects ventilation deficits in paediatric stem ［42］ GLANVILLE A R，BENDEN C，BERGERON A，et al.
cell transplant patients unable to perform spirometry［J］. Bronchiolitis obliterans syndrome after lung or haemato⁃
Eur Respir J，2019，53（5）：1801779 poietic stem cell transplantation：current management
［33］RAM S，VERLEDEN S E，BELL A J，et al. Quantitative and future directions［J］. ERJ Open Res，2022，8（3）：
CT correlates with local inflammation in lung of patients 00185-02022
with subtypes of chronic lung allograft dysfunction［J］. ［43］ERASMUS D B，DURAND N，ALVAREZ F A，et al. Fea⁃
Cells，2022，11（4）：699 sibility and safety of low ⁃dose mesenchymal stem cell
［34］KUBO Y，SUGIMOTO S，SHIOTANI T，et al. Percentage infusion in lung transplant recipients［J］. Stem Cells
of low attenuation area on computed tomography detects Transl Med，2022，11（9）：891-899
chronic lung allograft dysfunction，especially bronchiolitis ［44］MALARD F，MOHTY M. Updates in chronic graft⁃versus⁃
obliterans syndrome，after bilateral lung transplantation［J］. host disease management［J］. Am J Hematol，2023，98
Clin Transplant，2023，37（11）：e15077 （10）：1637-1644
［35］VASILEVA A，HANAFI N，HUSZTI E，et al. Intra⁃sub⁃ ［45］ BENAZZO A，BAGNERA C，IUS F，et al. A European
ject variability in oscillometry correlates with acute rejec⁃ multi ⁃ center analysis of extracorporeal photopheresis as
tion and CLAD post⁃lung transplant［J］. Front Med（Lau⁃ therapy for chronic lung allograft dysfunction［J］. Transpl
sanne），2023，10：1158870 Int，2024，36：11551
［36］KORDJAZY N，AMINI S. A review of the therapeutic ［46］BENAZZO A，CHO A，AUNER S，et al. Extracorporeal
potential of the cysteinyl leukotriene antagonist Montelu⁃ photopheresis for the prevention of rejection after lung
kast in the treatment of bronchiolitis obliterans syndrome transplantation：a prospective randomised controlled trial
following lung and hematopoietic ⁃ stem cell transplanta⁃ ［J］. Eur Respir J，2025，65（2）：2400733
tion and its possible mechanisms［J］. Ther Adv Respir ［47］FISHER A J，WHITE M，GOUDIE N，et al. Extracorporeal
Dis，2024，18：17534666241232284 photopheresis（ECP）in the treatment of chronic lung
［37］VOS R，VANDEN EYNDE R，RUTTENS D，et al. Monte⁃ allograft dysfunction（CLAD）：a prospective，multicentre，
lukast in chronic lung allograft dysfunction after lung open⁃label，randomised controlled trial studying the addi⁃
transplantation［J］. J Heart Lung Transplant，2019，38 tion of ECP to standard care in the treatment of bilateral
（5）：516-527 lung transplant patients with CLAD（E ⁃ CLAD UK）［J］.
［38］KRAHELSKI O，ALI I，NAMGOONG C，et al. Interven⁃ BMJ Open Respir Res，2024，11（1）：e001995
tional anti ⁃ reflux management for gastro ⁃ oesophageal ［48］GENG⁃CAHUAYME A A A，SÁEZ⁃GIMÉNEZ B，ALT⁃
reflux disease in lung transplant recipients：a systematic ABAS⁃GONZÁLEZ M，et al. Efficacy and safety of total
review and meta⁃analysis［J］. Surg Endosc，2025，39（1）： lymphoid irradiation in different chronic lung allograft
19-38 dysfunction phenotypes［J］. Clin Transplant，2023，37
［39］ DELLGREN G，LUND T K，RAIVIO P，et al. Effect of （2）：e14891
once⁃per⁃day tacrolimus versus twice⁃per⁃day ciclosporin ［49］ LEBEER M，KAES J，LAMBRECH M，et al. Total lym⁃
on 3⁃year incidence of chronic lung allograft dysfunction phoid irradiation in progressive bronchiolitis obliterans
after lung transplantation in Scandinavia（ScanCLAD）：a syndrome after lung transplantation：a single⁃center expe⁃
multicentre randomised controlled trial［J］. Lancet Respir rience and review of literature［J］. Transpl Int，2020，33